Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury

Progress in Neurobiology

Volumn 95, Issue 3, 2011, Pages 352-372

  Helmy, Adel ^a   De Simoni, Maria Grazia ^b   Guilfoyle, Mathew R ^a   Carpenter, Keri L H ^a   Hutchinson, Peter J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Blood brain barrier; Cerebrospinal fluid; Cytokines; Inflammation; Microdialysis; Traumatic brain injury

Indexed keywords

ANGIOPOIETIN; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ARTERIAL BLOOD; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; ENCEPHALITIS; HUMAN; JUGULAR VEIN; MICRODIALYSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TRAUMATIC BRAIN INJURY;

ANGIOPOIETINS; ANIMALS; BIOLOGICAL MARKERS; BLOOD-BRAIN BARRIER; BRAIN INJURIES; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; HUMANS; INFLAMMATION; INTERLEUKINS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80054112773     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2011.09.003     Document Type: Review

References (269)

1. Ahn M.J., Sherwood E.R., Prough D.S., Lin C.Y., DeWitt D.S. The effects of traumatic brain injury on cerebral blood flow and brain tissue nitric oxide levels and cytokine expression. J. Neurotrauma 2004, 21:1431-1442.
2. Alavijeh M.S., Palmer A.M. Measurement of the pharmacokinetics and pharmacodynamics of neuroactive compounds. Neurobiol. Dis. 2010, 37:38-47.
3. Alexander J.J., Anderson A.J., Barnum S.R., Stevens B., Tenner A.J. The complement cascade: Yin-Yang in neuroinflammation - neuro-protection and -degeneration. J. Neurochem. 2008, 107:1169-1187.
4. Alves O.L., Doyle A.J., Clausen T., Gilman C., Bullock R. Evaluation of topiramate neuroprotective effect in severe TBI using microdialysis. Ann. N.Y. Acad. Sci. 2003, 993:25-34. (Discussion 48-53).
5. Amick J.E., Yandora K.A., Bell M.J., Wisniewski S.R., Adelson P.D., Carcillo J.A., Janesko K.L., DeKosky S.T., Carlos T.M., Clark R.S., Kochanek P.M. The Th1 versus Th2 cytokine profile in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatr. Crit. Care Med. 2001, 2:260-264.
6. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin. Immunol. 2008, 20:86-100.
7. Ao X., Wang X., Lennartz M.R., Loegering D.J., Stenken J.A. Multiplexed cytokine detection in microliter microdialysis samples obtained from activated cultured macrophages. J. Pharm. Biomed. Anal. 2006, 40:915-921.
8. Arend W.P. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 2002, 13:323-340.
9. Argaw A.T., Gurfein B.T., Zhang Y., Zameer A., John G.R. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. PNAS 2009, 106:1977-1982.
10. Argaw A.T., Zhang Y., Snyder B.J., Zhao M.-L., Kopp N., Lee S.C., Raine C.S., Brosnan C.F., John G.R. IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J. Immunol. 2006, 177:5574-5584.
11. Atkins C.M., Oliva A.A., Alonso O.F., Pearse D.D., Bramlett H.M., Dietrich W.D. Modulation of the cAMP signaling pathway after traumatic brain injury. Exp. Neurol. 2007, 208:145-158.
12. Baldwin S.A., Fugaccia I., Brown D.R., Brown L.V., Scheff S.W. blood-brain barrier breach following cortical contusion in the rat. J. Neurosurg. 1996, 85:476-481.
13. Ballabh P., Braun A., Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 2004, 16:1-13.
14. Banks W.A., Kastin A.J. Blood to brain transport of interleukin links the immune and central nervous systems. Life Sci. 1991, 48:PL117-PL121.
15. Basu A., Krady J.K., O'Malley M., Styren S.D., DeKosky S.T., Levison S.W. The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflammatory mediators in response to brain injury. J. Neurosci. 2002, 22:6071-6082.
16. Bauer A.T., Burgers H.F., Rabie T., Marti H.H. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J. Cereb. Blood Flow Metab. 2010, 30:837-848.
17. Becker P., Zieger S., Rother U., Lutz H., Osswald P.M. [Complement activation following head and brain trauma]. Anaesthesist 1987, 36:301-305.
18. Bell M.J., Kochanek P.M., Doughty L.A., Carcillo J.A., Adelson P.D., Clark R.S., Wisniewski S.R., Whalen M.J., DeKosky S.T. Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children. J. Neurotrauma 1997, 14:451-457.
19. Bellander B.M., Singhrao S.K., Ohlsson M., Mattsson P., Svensson M. Complement activation in the human brain after traumatic head injury. J. Neurotrauma 2001, 18:1295-1311.
20. Benveniste E.N., Sparacio S.M., Norris J.G., Grenett H.E., Fuller G.M. Induction and regulation of interleukin-6 gene expression in rat astrocytes. J. Neuroimmunol. 1990, 30:201-212.
21. Benveniste H. Brain microdialysis. J. Neurochem. 1989, 52:1667-1679.
22. Benveniste H., Hansen A.J., Ottosen N.S. Determination of brain interstitial concentrations by microdialysis. J. Neurochem. 1989, 52:1741-1750.
23. Berger R.P., Ta'asan S., Rand A., Lokshin A., Kochanek P. Multiplex assessment of serum biomarker concentrations in well-appearing children with inflicted traumatic brain injury. Pediatr. Res. 2009, 65:97-102.
24. Bermpohl D., You Z., Lo E.H., Kim H.H., Whalen M.J. TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice. J. Cereb. Blood Flow Metab. 2007, 27:1806-1818.
25. Blamire A.M., Anthony D.C., Rajagopalan B., Sibson N.R., Perry V.H., Styles P. Interleukin-1β-induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: a magnetic resonance study. J. Neurosci. 2000, 20:8153-8159.
26. Blanchette M., Fortin D. blood-brain barrier disruption in the treatment of brain tumors. Methods Mol. Biol. 2011, 686:447-463.
27. Bongiovanni R., Kirkbride B., Newbould E., Durkalski V., Jaskiw G.E. Relationships between large neutral amino acid levels in plasma, cerebrospinal fluid, brain microdialysate and brain tissue in the rat. Brain Res. 2010, 1334:45-57.
28. Buttram S.D., Wisniewski S.R., Jackson E.K., Adelson P.D., Feldman K., Bayir H., Berger R.P., Clark R.S., Kochanek P.M. Multiplex assessment of cytokine and chemokine levels in cerebrospinal fluid following severe pediatric traumatic brain injury: effects of moderate hypothermia. J. Neurotrauma 2007, 24:1707-1717.
29. Bye N., Habgood M.D., Callaway J.K., Malakooti N., Potter A., Kossmann T., Morganti-Kossmann M.C. Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration. Exp. Neurol. 2007, 204:220-233.
30. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inglis J.D., Oldstone M.B., Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:10061-10065.
31. Carlson N.G., Wieggel W.A., Chen J., Bacchi A., Rogers S.W., Gahring L.C. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J. Immunol. 1999, 163:3963-3968.
32. Cederberg D., Siesjo P. What has inflammation to do with traumatic brain injury?. Childs Nerv. Syst. 2010, 26:221-226.
33. Cernak I. Animal models of head trauma. NeuroRx 2005, 2:410-422.
34. Chao C.C., Hu S., Ehrlich L., Peterson P.K. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-d-aspartate receptors. Brain Behav. Immun. 1995, 9:355-365.
35. Chen G., Shi J.X., Hang C.H., Xie W., Liu J., Liu X. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO). Neurosci. Lett. 2007, 425:177-182.
36. Chen G., Zhang S., Shi J., Ai J., Qi M., Hang C. Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4/NF-kappaB pathway. Exp. Neurol. 2009, 216:398-406.
37. Chen J., Braet F., Brodsky S., Weinstein T., Romanov V., Noiri E., Goligorsky M.S. VEGF-induced mobilization of caveolae and increase in permeability of endothelial cells. Am. J. Physiol. Cell Physiol. 2002, 282:C1053-C1063.
38. Chen S.F., Hsu C.W., Huang W.H., Wang J.Y. Post-injury baicalein improves histological and functional outcomes and reduces inflammatory cytokines after experimental traumatic brain injury. Br. J. Pharmacol. 2008, 155:1279-1296.
39. Chiaretti A., Antonelli A., Mastrangelo A., Pezzotti P., Tortorolo L., Tosi F., Genovese O. Interleukin-6 and nerve growth factor upregulation correlates with improved outcome in children with severe traumatic brain injury. J. Neurotrauma 2008, 25:225-234.
40. Chiaretti A., Barone G., Riccardi R., Antonelli A., Pezzotti P., Genovese O., Tortorolo L., Conti G. NGF, DCX, and NSE upregulation correlates with severity and outcome of head trauma in children. Neurology 2009, 72:609-616.
41. Chiaretti A., Genovese O., Aloe L., Antonelli A., Piastra M., Polidori G., Di Rocco C. Interleukin 1beta and interleukin 6 relationship with paediatric head trauma severity and outcome. Childs Nerv. Syst. 2005, 21:185-193. discussion 194.
42. Chio C.C., Lin J.W., Chang M.W., Wang C.C., Kuo J.R., Yang C.Z., Chang C.P. Therapeutic evaluation of etanercept in a model of traumatic brain injury. J. Neurochem. 2010, 115:921-929.
43. Chodobski A., Chung I., Kozniewska E., Ivanenko T., Chang W., Harrington J.F., Duncan J.A., Szmydynger-Chodob J. Early neutrophilic expression of vascular endothelial growth factor after traumatic brain injury. Neuroscience 2003, 122:853-867.
44. Choi S.J., Lee K.H., Park H.S., Kim S.K., Koh C.M., Park J.Y. Differential expression, shedding, cytokine regulation and function of TNFR1 and TNFR2 in human fetal astrocytes. Yonsei Med. J. 2005, 46:818-826.
45. Ciallella J.R., Ikonomovic M.D., Paljug W.R., Wilbur Y.I., Dixon C.E., Kochanek P.M., Marion D.W., DeKosky S.T. Changes in expression of amyloid precursor protein and interleukin-1beta after experimental traumatic brain injury in rats. J. Neurotrauma 2002, 19:1555-1567.
46. Clausen F., Hanell A., Bjork M., Hillered L., Mir A.K., Gram H., Marklund N. Neutralization of interleukin-1beta modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice. Eur. J. Neurosci. 2009, 30:385-396.
47. Clausen F., Hanell A., Israelsson C., Hedin J., Ebendal T., Mir A.K., Gram H., Marklund N. Neutralization of interleukin-1beta reduces cerebral edema and tissue loss and improves late cognitive outcome following traumatic brain injury in mice. Eur. J. Neurosci. 2011, 34:110-123.
48. Cobbs C.S., Chen J., Greenberg D.A., Graham S.H. Vascular endothelial growth factor expression in transient focal cerebral ischemia in the rat. Neurosci. Lett. 1998, 249:79-82.
49. Corletto F., Beech J., Raha-Chowdhury R., Skepper J., Menon D. YC-1, a HIF-1a inhibitor, reduces contusion volume and cerebral oedema 24hours after controlled cortical impact injury in the rat. J. Neurotrauma 2009, 26:A96.
50. Corletto F., Beech J., Skepper J., Menon D. Characterization of expression of hypoxia inducible factor 1 alpha in a rat model of traumatic brain injury. J. Neurotrauma 2009, 26:A39.
51. Csuka E., Morganti-Kossmann M.C., Lenzlinger P.M., Joller H., Trentz O., Kossmann T. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function. J. Neuroimmunol. 1999, 101:211-221.
52. Czosnyka M., Brady K., Reinhard M., Smielewski P., Steiner L.A. Monitoring of cerebrovascular autoregulation: facts, myths, and missing links. Neurocrit. Care 2009, 10:373-386.
53. Czosnyka M., Czosnyka Z., Momjian S., Pickard J.D. Cerebrospinal fluid dynamics. Physiol. Meas. 2004, 25:R51-R76.
54. Dahlin A.P., Wetterhall M., Caldwell K.D., Larsson A., Bergquist J., Hillered L., Hjort K. Methodological aspects on microdialysis protein sampling and quantification in biological fluids: an in vitro study on human ventricular CSF. Anal. Chem. 2010, 82:4376-4385.
55. Denes A., Thornton P., Rothwell N.J., Allan S.M. Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav. Immun. 2010, 24:708-723.
56. Deshmane S.L., Kremlev S., Amini S., Sawaya B.E. Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interferon Cytokine Res. 2009, 29:313-326.
57. Dinarello C., Arend W., Sims J., Smith D., Blumberg H., O'Neill L., Goldbach-Mansky R., Pizarro T., Hoffman H., Bufler P., Nold M., Ghezzi P., Mantovani A., Garlanda C., Boraschi D., Rubartelli A., Netea M., van der Meer J., Joosten L., Mandrup-Poulsen T., Donath M., Lewis E., Pfeilschifter J., Martin M., Kracht M., Muehl H., Novick D., Lukic M., Conti B., Solinger A., Kelk P., van de Veerdonk F., Gabel C. IL-1 family nomenclature. Nat. Immunol. 2010, 11:973.
58. Dore-Duffy P., Wang X., Mehedi A., Kreipke C.W., Rafols J.A. Differential expression of capillary VEGF isoforms following traumatic brain injury. Neurol. Res. 2007, 29:395-403.
59. Downen M., Amaral T.D., Hua L.L., Zhao M.L., Lee S.C. Neuronal death in cytokine-activated primary human brain cell culture: role of tumor necrosis factor-alpha. Glia 1999, 28:114-127.
60. Duo J., Stenken J.A. Heparin-immobilized microspheres for the capture of cytokines. Anal. Bioanal. Chem. 2011, 399:773-782.
61. Duo J., Stenken J.A. In vitro and in vivo affinity microdialysis sampling of cytokines using heparin-immobilized microspheres. Anal. Bioanal. Chem. 2011, 399:783-793.
62. Eriksson L., Antti H., Gottfries J., Holmes E., Johansson E., Lindgren F., Long I., Lundstedt T., Trygg J., Wold S. Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm). Anal. Bioanal. Chem. 2004, 380:419-429.
63. Fabry Z., Fitzsimmons K.M., Herlein J.A., Moninger T.O., Dobbs M.B., Hart M.N. Production of the cytokines interleukin 1 and 6 by murine brain microvessel endothelium and smooth muscle pericytes. J. Neuroimmunol. 1993, 47:23-34.
64. Fan L., Young P.R., Barone F.C., Feuerstein G.Z., Smith D.H., McIntosh T.K. Experimental brain injury induces expression of interleukin-1 beta mRNA in the rat brain. Brain Res. Mol. Brain Res. 1995, 30:125-130.
65. Fassbender K., Mielke O., Bertsch T., Muehlhauser F., Hennerici M., Kurimoto M., Rossol S. Interferon-gamma-inducing factor (IL-18) and interferon-gamma in inflammatory CNS diseases. Neurology 1999, 53:1104-1106.
66. Fassbender K., Schneider S., Bertsch T., Schlueter D., Fatar M., Ragoschke A., Kuhl S., Kischka U., Hennerici M. Temporal profile of release of interleukin-1beta in neurotrauma. Neurosci. Lett. 2000, 284:135-138.
67. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 2004, 25:581-611.
68. Fischer S., Clauss M., Wiesnet M., Renz D., Schaper W., Karliczek G.F. Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO. Am. J. Physiol. Cell Physiol. 1999, 276:C812-C820.
69. Folkersma H., Breve J.J., Tilders F.J., Cherian L., Robertson C.S., Vandertop W.P. Cerebral microdialysis of interleukin (IL)-1beta and IL-6: extraction efficiency and production in the acute phase after severe traumatic brain injury in rats. Acta Neurochir. (Wien) 2008, 150:1277-1284. discussion 1284.
70. Frugier T., Morganti-Kossmann M.C., O'Reilly D., McLean C.A. In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury. J. Neurotrauma 2010, 27:497-507.
71. Galea J., Ogungbenro K., Hulme S., Greenhalgh A., Aarons L., Scarth S., Hutchinson P., Grainger S., King A., Hopkins S.J., Rothwell N., Tyrrell P. Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study. J. Cereb. Blood Flow Metab. 2010, 31:439-447.
72. Gasque P., Dean Y.D., McGreal E.P., VanBeek J., Morgan B.P. Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology 2000, 49:171-186.
73. Gidday J.M., Gasche Y.G., Copin J.-C., Shah A.R., Perez R.S., Shapiro S.D., Chan P.H., Park T.S. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H558-H568.
74. Goodman J.C., Van M., Gopinath S.P., Robertson C.S. Pro-inflammatory and pro-apoptotic elements of the neuroinflammatory response are activated in traumatic brain injury. Acta Neurochir. Suppl. 2008, 102:437-439.
75. Gopcevic A., Mazul-Sunko B., Marout J., Sekulic A., Antoljak N., Siranovic M., Ivanec Z., Margaritoni M., Bekavac-Beslin M., Zarkovic N. Plasma interleukin-8 as a potential predictor of mortality in adult patients with severe traumatic brain injury. Tohoku J. Exp. Med. 2007, 211:387-393.
76. Goss J.R., Styren S.D., Miller P.D., Kochanek P.M., Palmer A.M., Marion D.W., DeKosky S.T. Hypothermia attenuates the normal increase in interleukin 1 beta RNA and nerve growth factor following traumatic brain injury in the rat. J. Neurotrauma. 1995, 12:159-167.
77. Gracie J.A., Robertson S.E., McInnes I.B. Interleukin-18. J. Leukoc. Biol. 2003, 73:213-224.
78. Graetz D., Nagel A., Schlenk F., Sakowitz O., Vajkoczy P., Sarrafzadeh A. High ICP as trigger of proinflammatory IL-6 cytokine activation in aneurysmal subarachnoid hemorrhage. Neurol. Res. 2009, 32:728-735.
79. Griffiths M.R., Gasque P., Neal J.W. The multiple roles of the innate immune system in the regulation of apoptosis and inflammation in the brain. J. Neuropathol. Exp. Neurol. 2009, 68:217-226.
80. Hadjigeorgiou G.M., Paterakis K., Dardiotis E., Dardioti M., Aggelakis K., Tasiou A., Xiromerisiou G., Komnos A., Zintzaras E., Scarmeas N., Papadimitriou A., Karantanas A. IL-1RN and IL-1B gene polymorphisms and cerebral hemorrhagic events after traumatic brain injury. Neurology 2005, 65:1077-1082.
81. Hang C.H., Shi J.X., Tian J., Li J.S., Wu W., Yin H.X. Effect of systemic LPS injection on cortical NF-kappaB activity and inflammatory response following traumatic brain injury in rats. Brain Res. 2004, 1026:23-32.
82. Harper S.J., Bates D.O. VEGF - a splicing: the key to anti-angiogenic therapeutics?. Nat. Rev. Cancer 2008, 8:880-887.
83. Hayakata T., Shiozaki T., Tasaki O., Ikegawa H., Inoue Y., Toshiyuki F., Hosotubo H., Kieko F., Yamashita T., Tanaka H., Shimazu T., Sugimoto H. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock 2004, 22:102-107.
84. Hayashi T., Abe K., Itoyama Y. Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J. Cereb. Blood Flow Metab. 1998, 18:887-895.
85. Hedtjarn M., Leverin A.L., Eriksson K., Blomgren K., Mallard C., Hagberg H. Interleukin-18 involvement in hypoxic-ischemic brain injury. J. Neurosci. 2002, 22:5910-5919.
86. Helmy A., Carpenter K.L., Hutchinson P.J. Microdialysis in the human brain and its potential role in the development and clinical assessment of drugs. Curr. Med. Chem. 2007, 14:1525-1537.
87. Helmy A., Carpenter K.L., Menon D.K., Pickard J.D., Hutchinson P.J. The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production. J. Cereb. Blood Flow Metab. 2010.
88. Helmy A., Carpenter K.L., Menon D.K., Pickard J.D., Hutchinson P.J. The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production. J. Cereb. Blood Flow Metab. 2011, 31:658-670.
89. Helmy A., Carpenter K.L., Skepper J.N., Kirkpatrick P.J., Pickard J.D., Hutchinson P.J. Microdialysis of cytokines: methodological considerations, scanning electron microscopy, and determination of relative recovery. J. Neurotrauma 2009, 26:549-561.
90. Helmy A., Timofeev I., Palmer C.R., Gore A., Menon D.K., Hutchinson P.J. Hierarchical log linear analysis of admission blood parameters and clinical outcome following traumatic brain injury. Acta Neurochir. (Wien) 2010, 152:953-957.
91. Helmy A., Vizcaychipi M., Gupta A.K. Traumatic brain injury: intensive care management. Br. J. Anaesth. 2007, 99:32-42.
92. Hergenroeder G.W., Moore A.N., McCoy J.P., Samsel L., Ward N.H., Clifton G.L., Dash P.K. Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. J. Neuroinflamm. 2010, 7:19.
93. Hillered L., Vespa P.M., Hovda D.A. Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis. J. Neurotrauma 2005, 22:3-41.
94. Hillman J., Aneman O., Anderson C., Sjogren F., Saberg C., Mellergard P. A microdialysis technique for routine measurement of macromolecules in the injured human brain. Neurosurgery 2005, 56:1264-1268. (Discussion 1268-1270).
95. Hillman J., Aneman O., Persson M., Andersson C., Dabrosin C., Mellergard P. Variations in the response of interleukins in neurosurgical intensive care patients monitored using intracerebral microdialysis. J. Neurosurg. 2007, 106:820-825.
96. Holmin S., Hojeberg B. In situ detection of intracerebral cytokine expression after human brain contusion. Neurosci. Lett. 2004, 369:108-114.
97. Huang T.Y., Chung H.W., Chen M.Y., Giiang L.H., Chin S.C., Lee C.S., Chen C.Y., Liu Y.J. Supratentorial cerebrospinal fluid production rate in healthy adults: quantification with two-dimensional cine phase-contrast MR imaging with high temporal and spatial resolution. Radiology 2004, 233:603-608.
98. Hutchinson P.J., O'Connell M.T., Rothwell N.J., Hopkins S.J., Nortje J., Carpenter K.L., Timofeev I., Al-Rawi P.G., Menon D.K., Pickard J.D. Inflammation in human brain injury: intracerebral concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1ra. J. Neurotrauma 2007, 24:1545-1557.
99. Issa R., Krupinski J., Bujny T., Kumar S., Kaluza J., Kumar P. Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischemic stroke. Lab. Invest. 1999, 79:417-425.
100. Janowitz T., Menon D.K. Exploring new routes for neuroprotective drug development in traumatic brain injury. Sci. Transl. Med. 2010, 2:27rv21.
101. Johanson C.E., Stopa E.G., McMillan P.N. The blood-cerebrospinal fluid barrier: structure and functional significance. Methods Mol. Biol. 2010, 686:101-131.
102. Jones N.C., Prior M.J., Burden-Teh E., Marsden C.A., Morris P.G., Murphy S. Antagonism of the interleukin-1 receptor following traumatic brain injury in the mouse reduces the number of nitric oxide synthase-2-positive cells and improves anatomical and functional outcomes. Eur. J. Neurosci. 2005, 22:72-78.
103. Kaczorowski S.L., Schiding J.K., Toth C.A., Kochanek P.M. Effect of soluble complement receptor-1 on neutrophil accumulation after traumatic brain injury in rats. J. Cereb. Blood Flow Metab. 1995, 15:860-864.
104. Kadhim H.J., Duchateau J., Sebire G. Cytokines and brain injury: invited review. J. Intensive Care Med. 2008, 23:236-249.
105. Kamm K., Vanderkolk W., Lawrence C., Jonker M., Davis A.T. The effect of traumatic brain injury upon the concentration and expression of interleukin-1beta and interleukin-10 in the rat. J. Trauma. 2006, 60:152-157.
106. Keyrouz S.G., Diringer M.N. Clinical review: prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit. Care 2007, 11:220.
107. Khuman J., Meehan W.P., Zhu X., Qiu J., Hoffmann U., Zhang J., Giovannone E., Lo E.H., Whalen M.J. Tumor necrosis factor alpha and Fas receptor contribute to cognitive deficits independent of cell death after concussive traumatic brain injury in mice. J. Cereb. Blood Flow Metab. 2011, 31:778-789.
108. Kim H., Lee J.M., Park J.S., Jo S.A., Kim Y.O., Kim C.W., Jo I. Dexamethasone coordinately regulates angiopoietin-1 and VEGF: a mechanism of glucocorticoid-induced stabilization of blood-brain barrier. Biochem. Biophys. Res. Commun. 2008, 372:243-248.
109. Kim K.S., Wass C.A., Cross A.S., Opal S.M. Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat. Lymphokine Cytokine Res. 1992, 11:293-298.
110. Kinoshita K., Chatzipanteli K., Vitarbo E., Truettner J.S., Alonso O.F., Dietrich W.D. Interleukin-1beta messenger ribonucleic acid and protein levels after fluid-percussion brain injury in rats: importance of injury severity and brain temperature. Neurosurgery 2002, 51:195-203. discussion 203.
111. Kirchhoff C., Buhmann S., Bogner V., Stegmaier J., Leidel B.A., Braunstein V., Mutschler W., Biberthaler P. Cerebrospinal IL-10 concentration is elevated in non-survivors as compared to survivors after severe traumatic brain injury. Eur. J. Med. Res. 2008, 13:464-468.
112. Kita T., Liu L., Tanaka N., Kinoshita Y. The expression of tumor necrosis factor-alpha in the rat brain after fluid percussive injury. Int. J. Legal Med. 1997, 110:305-311.
113. Knoblach S.M., Faden A.I. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp. Neurol. 1998, 153:143-151.
114. Knoblach S.M., Faden A.I. Cortical interleukin-1 beta elevation after traumatic brain injury in the rat: no effect of two selective antagonists on motor recovery. Neurosci. Lett. 2000, 289:5-8.
115. Knoblach S.M., Fan L., Faden A.I. Early neuronal expression of tumor necrosis factor-alpha after experimental brain injury contributes to neurological impairment. J. Neuroimmunol. 1999, 95:115-125.
116. Kornhuber J., Weigmann H., Rohrich J., Wiltfang J., Bleich S., Meineke I., Zochling R., Hartter S., Riederer P., Hiemke C. Region specific distribution of levomepromazine in the human brain. J. Neural. Transm. 2006, 113:387-397.
117. Kossmann T., Hans V., Imhof H.G., Trentz O., Morganti-Kossmann M.C. Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res. 1996, 713:143-152.
118. Kossmann T., Stahel P.F., Lenzlinger P.M., Redl H., Dubs R.W., Trentz O., Schlag G., Morganti-Kossmann M.C. Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. J. Cereb. Blood Flow Metab. 1997, 17:280-289.
119. Kossmann T., Stahel P.F., Morganti-Kossmann M.C., Jones J.L., Barnum S.R. Elevated levels of the complement components C3 and factor B in ventricular cerebrospinal fluid of patients with traumatic brain injury. J. Neuroimmunol. 1997, 73:63-69.
120. Kovacs Z., Ikezaki K., Samoto K., Inamura T., Fukui M., Kawamata T., Finklestein S.P. VEGF and flt: expression time kinetics in rat brain infarct. Stroke 1996, 27:1865-1873.
121. Koyama J., Miyake S., Sasayama T., Kondoh T., Kohmura E. Effect of VEGF receptor antagonist (VGA1155) on brain edema in the rat cold injury model. Kobe J. Med. Sci. 2007, 53:199-207.
122. Kremlev S.G., Palmer C. Interleukin-10 inhibits endotoxin-induced pro-inflammatory cytokines in microglial cell cultures. J. Neuroimmunol. 2005, 162:71-80.
123. Krueger J.M. The role of cytokines in sleep regulation. Curr. Pharm. Des. 2008, 14:3408-3416.
124. Krum J.M., Mani N., Rosenstein J.M. Roles of the endogenous VEGF receptors flt-1 and flk-1 in astroglial and vascular remodeling after brain injury. Exp. Neurol. 2008, 212:108-117.
125. Kumai Y., Ooboshi H., Ibayashi S., Ishikawa E., Sugimori H., Kamouchi M., Kitazono T., Egashira K., Iida M. Postischemic gene transfer of soluble Flt-1 protects against brain ischemia with marked attenuation of blood-brain barrier permeability. J. Cereb. Blood Flow Metab. 2007, 27:1152-1160.
126. Kushi H., Saito T., Makino K., Hayashi N. IL-8 is a key mediator of neuroinflammation in severe traumatic brain injuries. Acta Neurochir. Suppl. 2003, 86:347-350.
127. Lawrence C.B., Allan S.M., Rothwell N.J. Interleukin-1beta and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Eur. J. Neurosci. 1998, 10:1188-1195.
128. Lee G.J., Park J.H., Park H.K. Microdialysis applications in neuroscience. Neurol. Res. 2008, 30:661-668.
129. Lee S.W., Kim W.J., Jun H.O., Choi Y.K., Kim K.W. Angiopoietin-1 reduces vascular endothelial growth factor-induced brain endothelial permeability via upregulation of ZO-2. Int. J. Mol. Med. 2009, 23:279-284.
130. Leinhase I., Holers V.M., Thurman J.M., Harhausen D., Schmidt O.I., Pietzcker M., Taha M.E., Rittirsch D., Huber-Lang M., Smith W.R., Ward P.A., Stahel P.F. Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation. BMC Neurosci. 2006, 7:55.
131. Leinhase I., Schmidt O.I., Thurman J.M., Hossini A.M., Rozanski M., Taha M.E., Scheffler A., John T., Smith W.R., Holers V.M., Stahel P.F. Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury. Exp. Neurol. 2006, 199:454-464.
132. Lennmyr F., Ata K.A., Funa K., Olsson Y., Terent A. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. J. Neuropathol. Exp. Neurol. 1998, 57:874-882.
133. Li K., Sacks S.H., Zhou W. The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies. Mol. Immunol. 2007, 44:3866-3874.
134. Li L., Lu J., Tay S.S., Moochhala S.M., He B.P. The function of microglia, either neuroprotection or neurotoxicity, is determined by the equilibrium among factors released from activated microglia in vitro. Brain Res. 2007, 1159:8-17.
135. Lindefors N., Amberg G., Ungerstedt U. Intracerebral microdialysis: I. Experimental studies of diffusion kinetics. J. Pharmacol. Methods 1989, 22:141-156.
136. Lindsberg P.J., Ohman J., Lehto T., Karjalainen-Lindsberg M.L., Paetau A., Wuorimaa T., Carpen O., Kaste M., Meri S. Complement activation in the central nervous system following blood-brain barrier damage in man. Ann. Neurol. 1996, 40:587-596.
137. Liu X., Van Natta K., Yeo H., Vilenski O., Weller P.E., Worboys P.D., Monshouwer M. Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid. Drug Metab. Dispos. 2009, 37:787-793.
138. Lloyd E., Somera-Molina K., Van Eldik L.J., Watterson D.M., Wainwright M.S. Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury. J. Neuroinflamm. 2008, 5:28.
139. Longhi L., Ortolano F., Zanier E.R., Perego C., Stocchetti N., De Simoni M.G. Effect of traumatic brain injury on cognitive function in mice lacking p55 and p75 tumor necrosis factor receptors. Acta Neurochir. Suppl. 2008, 102:409-413.
140. Longhi L., Perego C., Ortolano F., Zanier E.R., Bianchi P., Stocchetti N., McIntosh T.K., De Simoni M.G. C1-inhibitor attenuates neurobehavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice. Crit. Care Med. 2009, 37:659-665.
141. Lotocki G., Vaccari J.P., Perez E.R., Sanchez-Molano J., Furones-Alonso O., Bramlett H.M., Dietrich W.D. Alterations in blood-brain barrier permeability to large and small molecules and leukocyte accumulation after traumatic brain injury: effects of post-traumatic hypothermia. J. Neurotrauma 2009, 26:1123-1134.
142. Lu K.T., Wang Y.W., Wo Y.Y., Yang Y.L. Extracellular signal-regulated kinase-mediated IL-1-induced cortical neuron damage during traumatic brain injury. Neurosci. Lett. 2005, 386:40-45.
143. Lu K.T., Wang Y.W., Yang J.T., Yang Y.L., Chen H.I. Effect of interleukin-1 on traumatic brain injury-induced damage to hippocampal neurons. J. Neurotrauma 2005, 22:885-895.
144. Lu K.T., Wu C.Y., Yen H.H., Peng J.H., Wang C.L., Yang Y.L. Bumetanide administration attenuated traumatic brain injury through IL-1 overexpression. Neurol. Res. 2007, 29:404-409.
145. Maas A.I., Murray G., Henney H., Kassem N., Legrand V., Mangelus M., Muizelaar J.P., Stocchetti N., Knoller N. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurol. 2006, 5:38-45.
146. Maas A.I., Stocchetti N., Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008, 7:728-741.
147. MacEwan D.J. TNF receptor subtype signalling: differences and cellular consequences. Cell Signal. 2002, 14:477-492.
148. Maegele M., Sauerland S., Bouillon B., Schafer U., Trubel H., Riess P., Neugebauer E.A. Differential immunoresponses following experimental traumatic brain injury, bone fracture and " two-hit" -combined neurotrauma. Inflamm. Res. 2007, 56:318-323.
149. Macmillan C.S., Andrews P.J. Cerebrovenous oxygen saturation monitoring: practical considerations and clinical relevance. Intensive Care Med. 2000, 26:1028-1036.
150. Maier B., Laurer H.L., Rose S., Buurman W.A., Marzi I. Physiological levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: a normative study. J. Neurotrauma 2005, 22:822-835.
151. Maier B., Lehnert M., Laurer H.L., Marzi I. Biphasic elevation in cerebrospinal fluid and plasma concentrations of endothelin 1 after traumatic brain injury in human patients. Shock 2007, 27:610-614.
152. Maier B., Schwerdtfeger K., Mautes A., Holanda M., Muller M., Steudel W.I., Marzi I. Differential release of interleukines 6, 8, and 10 in cerebrospinal fluid and plasma after traumatic brain injury. Shock 2001, 15:421-426.
153. Marcus H.J., Carpenter K.L., Price S.J., Hutchinson P.J. In vivo assessment of high-grade glioma biochemistry using microdialysis: a study of energy-related molecules, growth factors and cytokines. J. Neurooncol. 2010, 97:11-23.
154. Marklund N., Hillered L. Animal modeling of traumatic brain injury in pre-clinical drug development - where do we go from here?. Br. J. Pharmacol. 2010.
155. McKeating E.G., Andrews P.J., Signorini D.F., Mascia L. Transcranial cytokine gradients in patients requiring intensive care after acute brain injury. Br. J. Anaesth. 1997, 78:520-523.
156. Mellergard P., Aneman O., Sjogren F., Pettersson P., Hillman J. Changes in extracellular concentrations of some cytokines, chemokines, and neurotrophic factors after insertion of intracerebral microdialysis catheters in neurosurgical patients. Neurosurgery 2008, 62:151-157. discussion 157-158.
157. Mellergard P., Aneman O., Sjogren F., Saberg C., Hillman J. Differences in cerebral extracellular response of interleukin-1beta, interleukin-6, and interleukin-10 after subarachnoid hemorrhage or severe head trauma in humans. Neurosurgery 2011, 68:12-19. discussion 19.
158. Mellergard P., Sjogren F., Hillman J. Release of VEGF and FGF in the extracellular space following severe subarachnoidal haemorrhage or traumatic head injury in humans. Br. J. Neurosurg. 2010, 24:261-267.
159. Menge T., Jander S., Stoll G. Induction of the proinflammatory cytokine interleukin-18 by axonal injury. J. Neurosci. Res. 2001, 65:332-339.
160. Mindermann T., Zimmerli W., Gratzl O. Rifampin concentrations in various compartments of the human brain: a novel method for determining drug levels in the cerebral extracellular space. Antimicrob. Agents Chemother. 1998, 42:2626-2629.
161. Morales D.M., Marklund N., Lebold D., Thompson H.J., Pitkanen A., Maxwell W.L., Longhi L., Laurer H., Maegele M., Neugebauer E., Graham D.I., Stocchetti N., McIntosh T.K. Experimental models of traumatic brain injury: do we really need to build a better mousetrap?. Neuroscience 2005, 136:971-989.
162. Morris G.F., Bullock R., Marshall S.B., Marmarou A., Maas A., Marshall L.F. Failure of the competitive N-methyl-d-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators. J. Neurosurg. 1999, 91:737-743.
163. Muller M., Schwerdtfeger K., Maier B., Mautes A., Schiedat T., Bianchi O., Marzi I. Cerebral blood flow velocity and inflammatory response after severe traumatic brain injury. Eur. J. Ultrasound 2001, 12:203-208.
164. Murakami K., Kondo T., Yang G., Chen S.F., Morita-Fujimura Y., Chan P.H. Cold injury in mice: a model to study mechanisms of brain edema and neuronal apoptosis. Prog. Neurobiol. 1999, 57:289-299.
165. Nag S., Manias J.L., Stewart D.J. Pathology and new players in the pathogenesis of brain edema. Acta Neuropathol. 2009, 118:197-217.
166. Nag S., Papneja T., Venugopalan R., Stewart D.J. Increased angiopoietin2 expression is associated with endothelial apoptosis and blood-brain barrier breakdown. Lab. Invest. 2005, 85:1189-1198.
167. Nag S., Takahashi J.L., Kilty D.W. Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma. J. Neuropathol. Exp. Neurol. 1997, 56:912-921.
168. Narayan R.K., Michel M.E., Ansell B., Baethmann A., Biegon A., Bracken M.B., Bullock M.R., Choi S.C., Clifton G.L., Contant C.F., Coplin W.M., Dietrich W.D., Ghajar J., Grady S.M., Grossman R.G., Hall E.D., Heetderks W., Hovda D.A., Jallo J., Katz R.L., Knoller N., Kochanek P.M., Maas A.I., Majde J., Marion D.W., Marmarou A., Marshall L.F., McIntosh T.K., Miller E., Mohberg N., Muizelaar J.P., Pitts L.H., Quinn P., Riesenfeld G., Robertson C.S., Strauss K.I., Teasdale G., Temkin N., Tuma R., Wade C., Walker M.D., Weinrich M., Whyte J., Wilberger J., Young A.B., Yurkewicz L. Clinical trials in head injury. J. Neurotrauma 2002, 19:503-557.
169. Nekludov M., Antovic J., Bredbacka S., Blomback M. Coagulation abnormalities associated with severe isolated traumatic brain injury: cerebral arterio-venous differences in coagulation and inflammatory markers. J. Neurotrauma 2007, 24:174-180.
170. Nourhaghighi N., Teichert-Kuliszew K., Davis J., Stewart D.J., Nag S. Altered expression of angiopoietins during blood-brain barrier breakdown and angiogenesis. Lab. Invest. 2003, 83:1211-1222.
171. O'Connor J.J., Coogan A.N. Actions of the pro-inflammatory cytokine IL-1 beta on central synaptic transmission. Exp. Physiol. 1999, 84:601-614.
172. O'Connor W.T., Smyth A., Gilchrist M.D. Animal models of traumatic brain injury: a critical evaluation. Pharmacol. Ther. 2011, 130:106-113.
173. Pan Y.F., Feng J., Cheng Q.Y., Li F.Z. Intracerebral microdialysis technique and its application on brain pharmacokinetic-pharmacodynamic study. Arch. Pharm. Res. 2007, 30:1635-1645.
174. Papavassiliou E., Gogate N., Proescholdt M., Heiss J.D., Walbridge S., Edwards N.A., Oldfield E.H., Merrill M.J. Vascular endothelial growth factor (vascular permeability factor) expression in injured rat brain. J. Neurosci. Res. 1997, 49:451-460.
175. Park K.M., Bowers W.J. Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction. Cell. Signal. 2010, 22:977-983.
176. Patel H.C., Bouamra O., Woodford M., King A.T., Yates D.W., Lecky F.E. Trends in head injury outcome from 1989 to 2003 and the effect of neurosurgical care: an observational study. Lancet 2005, 366:1538-1544.
177. Penkowa M., Camats J., Hadberg H., Quintana A., Rojas S., Giralt M., Molinero A., Campbell I.L., Hidalgo J. Astrocyte-targeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide. J. Neurosci. Res. 2003, 73:481-496.
178. Penkowa M., Hidalgo J. IL-6 deficiency leads to reduced metallothionein-I+II expression and increased oxidative stress in the brain stem after 6-aminonicotinamide treatment. Exp. Neurol. 2000, 163:72-84.
179. Perez-Barcena J., Ibanez J., Brell M., Crespi C., Frontera G., Llompart-Pou J.A., Homar J., Abadal J.M. Lack of correlation among intracerebral cytokines, intracranial pressure, and brain tissue oxygenation in patients with traumatic brain injury and diffuse lesions. Crit. Care Med. 2011, 39:533-540.
180. Pinteaux E., Trotter P., Simi A. Cell-specific and concentration-dependent actions of interleukin-1 in acute brain inflammation. Cytokine 2009, 45:1-7.
181. Plate K.H., Beck H., Danner S., Allegrini P.R., Wiessner C. Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct. J. Neuropathol. Exp. Neurol. 1999, 58:654-666.
182. Pleines U.E., Morganti-Kossmann M.C., Rancan M., Joller H., Trentz O., Kossmann T. S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J. Neurotrauma 2001, 18:491-498.
183. Pleines U.E., Stover J.F., Kossmann T., Trentz O., Morganti-Kossmann M.C. Soluble ICAM-1 in CSF coincides with the extent of cerebral damage in patients with severe traumatic brain injury. J. Neurotrauma 1998, 15:399-409.
184. Popovich P.G., Longbrake E.E. Can the immune system be harnessed to repair the CNS?. Nat. Rev. Neurosci. 2008, 9:481-493.
185. Quintana A., Giralt M., Rojas S., Penkowa M., Campbell I.L., Hidalgo J., Molinero A. Differential role of tumor necrosis factor receptors in mouse brain inflammatory responses in cryolesion brain injury. J. Neurosci. Res. 2005, 82:701-716.
186. Ramilo O., Saez-Llorens X., Mertsola J., Jafari H., Olsen K.D., Hansen E.J., Yoshinaga M., Ohkawara S., Nariuchi H., McCracken G.H. Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation. J. Exp. Med. 1990, 172:497-507.
187. Rancan M., Bye N., Otto V.I., Trentz O., Kossmann T., Frentzel S., Morganti-Kossmann M.C. The chemokine fractalkine in patients with severe traumatic brain injury and a mouse model of closed head injury. J. Cereb. Blood Flow Metab. 2004, 24:1110-1118.
188. Rancan M., Morganti-Kossmann M.C., Barnum S.R., Saft S., Schmidt O.I., Ertel W., Stahel P.F. Central nervous system-targeted complement inhibition mediates neuroprotection after closed head injury in transgenic mice. J. Cereb. Blood Flow Metab. 2003, 23:1070-1074.
189. Reyes T.M., Fabry Z., Coe C.L. Brain endothelial cell production of a neuroprotective cytokine, interleukin-6, in response to noxious stimuli. Brain Res. 1999, 851:215-220.
190. Roberts I., Yates D., Sandercock P., Farrell B., Wasserberg J., Lomas G., Cottingham R., Svoboda P., Brayley N., Mazairac G., Laloe V., Munoz-Sanchez A., Arango M., Hartzenberg B., Khamis H., Yutthakasemsunt S., Komolafe E., Olldashi F., Yadav Y., Murillo-Cabezas F., Shakur H., Edwards P. Effect of intravenous corticosteroids on death within 14 days in 10,008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 2004, 364:1321-1328.
191. Rollins B.J. Chemokines. Blood 1997, 90:909-928.
192. Rooker S., Jander S., Van Reempts J., Stoll G., Jorens P.G., Borgers M., Verlooy J. Spatiotemporal pattern of neuroinflammation after impact-acceleration closed head injury in the rat. Mediators Inflamm. 2006, 2006:90123.
193. Rosenberg G.A., Estrada E.Y., Dencoff J.E., Hsu C.Y. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998, 29:2189-2195. (Editorial comment).
194. Sanderson K.L., Raghupathi R., Saatman K.E., Martin D., Miller G., McIntosh T.K. Interleukin-1 receptor antagonist attenuates regional neuronal cell death and cognitive dysfunction after experimental brain injury. J. Cereb. Blood Flow Metab. 1999, 19:1118-1125.
195. Sarrafzadeh A., Schlenk F., Gericke C., Vajkoczy P. Relevance of cerebral interleukin-6 after aneurysmal subarachnoid hemorrhage. Neurocrit. Care 2010, 13:339-346.
196. Scherbel U., Raghupathi R., Nakamura M., Saatman K.E., Trojanowski J.Q., Neugebauer E., Marino M.W., McIntosh T.K. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:8721-8726.
197. Schmidt O.I., Heyde C.E., Ertel W., Stahel P.F. Closed head injury-an inflammatory disease?. Brain Res. Brain Res. Rev. 2005, 48:388-399.
198. Schutte R.J., Oshodi S.A., Reichert W.M. In vitro characterization of microdialysis sampling of macromolecules. Anal. Chem. 2004, 76:6058-6063.
199. Semple B.D., Bye N., Rancan M., Ziebell J.M., Morganti-Kossmann M.C. Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice. J. Cereb. Blood Flow Metab. 2010, 30:769-782.
200. Semple B.D., Bye N., Ziebell J.M., Morganti-Kossmann M.C. Deficiency of the chemokine receptor CXCR2 attenuates neutrophil infiltration and cortical damage following closed head injury. Neurobiol. Dis. 2010, 40:394-403.
201. Shen F., Su H., Fan Y., Chen Y., Zhu Y., Liu W., Young W.L., Yang G.-Y. Adeno-associated viral vector-mediated hypoxia-inducible vascular endothelial growth factor gene expression attenuates ischemic brain injury after focal cerebral ischemia in mice. Stroke 2006, 37:2601-2606.
202. Shiozaki T., Hayakata T., Tasaki O., Hosotubo H., Fuijita K., Mouri T., Tajima G., Kajino K., Nakae H., Tanaka H., Shimazu T., Sugimoto H. Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock 2005, 23:406-410.
203. Shohami E., Bass R., Wallach D., Yamin A., Gallily R. Inhibition of tumor necrosis factor alpha (TNFalpha) activity in rat brain is associated with cerebroprotection after closed head injury. J. Cereb. Blood Flow Metab. 1996, 16:378-384.
204. Shohami E., Gallily R., Mechoulam R., Bass R., Ben-Hur T. Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant. J. Neuroimmunol. 1997, 72:169-177.
205. Shohami E., Ginis I., Hallenbeck J.M. Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev. 1999, 10:119-130.
206. Shojo H., Kaneko Y., Mabuchi T., Kibayashi K., Adachi N., Borlongan C.V. Genetic and histologic evidence implicates role of inflammation in traumatic brain injury-induced apoptosis in the rat cerebral cortex following moderate fluid percussion injury. Neuroscience 2010, 171:1273-1282.
207. Shore P.M., Thomas N.J., Clark R.S., Adelson P.D., Wisniewski S.R., Janesko K.L., Bayir H., Jackson E.K., Kochanek P.M. Continuous versus intermittent cerebrospinal fluid drainage after severe traumatic brain injury in children: effect on biochemical markers. J. Neurotrauma 2004, 21:1113-1122.
208. Silverberg G.D., Heit G., Huhn S., Jaffe R.A., Chang S.D., Bronte-Stewart H., Rubenstein E., Possin K., Saul T.A. The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer's type. Neurology 2001, 57:1763-1766.
209. Simi A., Tsakiri N., Wang P., Rothwell N.J. Interleukin-1 and inflammatory neurodegeneration. Biochem. Soc. Trans. 2007, 35:1122-1126.
210. Singhal A., Baker A.J., Hare G.M., Reinders F.X., Schlichter L.C., Moulton R.J. Association between cerebrospinal fluid interleukin-6 concentrations and outcome after severe human traumatic brain injury. J. Neurotrauma 2002, 19:929-937.
211. Skold M.K., von Gertten C., Sandberg-Nordqvis A.C., Mathiesen T., Holmin S. VEGF and VEGF receptor expression after experimental brain contusion in rat. J. Neurotrauma 2005, 22:353-367.
212. Slevin M., Krupinski J., Slowik A., Kumar P., Szczudlik A., Gaffney J. Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke. Stroke 2000, 31:1863-1870.
213. Snyder K.L., Nathan C.E., Yee A., Stenken J.A. Diffusion and calibration properties of microdialysis sampling membranes in biological media. Analyst 2001, 126:1261-1268.
214. Stahel P.F., Kariya K., Shohami E., Barnum S.R., Eugster H., Trentz O., Kossmann T., Morganti-Kossmann M.C. Intracerebral complement C5a receptor (CD88) expression is regulated by TNF and lymphotoxin-alpha following closed head injury in mice. J. Neuroimmunol. 2000, 109:164-172.
215. Stahel P.F., Kossmann T., Joller H., Trentz O., Morganti-Kossmann M.C. Increased interleukin-12 levels in human cerebrospinal fluid following severe head trauma. Neurosci. Lett. 1998, 249:123-126.
216. Stahel P.F., Morganti-Kossmann M.C., Kossmann T. The role of the complement system in traumatic brain injury. Brain Res. Brain Res. Rev. 1998, 27:243-256.
217. Stahel P.F., Morganti-Kossmann M.C., Perez D., Redaelli C., Gloor B., Trentz O., Kossmann T. Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood-brain barrier dysfunction in patients with traumatic brain injury. J. Neurotrauma 2001, 18:773-781.
218. Stefini R., Catenacci E., Piva S., Sozzani S., Valerio A., Bergomi R., Cenzato M., Mortini P., Latronico N. Chemokine detection in the cerebral tissue of patients with posttraumatic brain contusions. J. Neurosurg. 2008, 108:958-962.
219. Stenken J.A., Church M.K., Gill C.A., Clough G.F. How minimally invasive is microdialysis sampling? A cautionary note for cytokine collection in human skin and other clinical studies. AAPS J. 2010, 12:73-78.
220. Stenken J.A., Lunte C.E., Southard M.Z., Stahle L. Factors that influence microdialysis recovery. Comparison of experimental and theoretical microdialysis recoveries in rat liver. J. Pharm. Sci. 1997, 86:958-966.
221. Storini C., Rossi E., Marrella V., Distaso M., Veerhuis R., Vergani C., Bergamaschini L., De Simoni M.G. C1-inhibitor protects against brain ischemia-reperfusion injury via inhibition of cell recruitment and inflammation. Neurobiol. Dis. 2005, 19:10-17.
222. Stover J.F., Schoning B., Beyer T.F., Woiciechowsky C., Unterberg A.W. Temporal profile of cerebrospinal fluid glutamate, interleukin-6, and tumor necrosis factor-alpha in relation to brain edema and contusion following controlled cortical impact injury in rats. Neurosci. Lett. 2000, 288:25-28.
223. Strijbos P.J., Rothwell N.J. Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J. Neurosci. 1995, 15:3468-3474.
224. Stroemer R.P., Rothwell N.J. Cortical protection by localized striatal injection of IL-1ra following cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 1997, 17:597-604.
225. Sullivan P.G., Bruce-Keller A.J., Rabchevsky A.G., Christakos S., Clair D.K., Mattson M.P., Scheff S.W. Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury. J. Neurosci. 1999, 19:6248-6256.
226. Suzuki S., Tanaka K., Suzuki N. Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J. Cereb. Blood Flow Metab. 2009, 29:464-479.
227. Swartz K.R., Liu F., Sewell D., Schochet T., Campbell I., Sandor M., Fabry Z. Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res. 2001, 896:86-95.
228. Sykova E., Nicholson C. Diffusion in brain extracellular space. Physiol. Rev. 2008, 88:1277-1340.
229. Tanriverdi T., Uzan M., Sanus G.Z., Baykara O., Is M., Ozkara C., Buyra N. Lack of association between the IL1A gene (-889) polymorphism and outcome after head injury. Surg. Neurol. 2006, 65:7-10. (Discussion 10).
230. Tehranian R., Andell-Jonsson S., Beni S.M., Yatsiv I., Shohami E., Bartfai T., Lundkvist J., Iverfeldt K. Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. J. Neurotrauma 2002, 19:939-951.
231. Thau-Zuchman O., Shohami E., Alexandrovich A.G., Leker R.R. Vascular endothelial growth factor increases neurogenesis after traumatic brain injury. J. Cereb. Blood Flow Metab. 2010, 30:1008-1016.
232. Thornton P., Pinteaux E., Gibson R.M., Allan S.M., Rothwell N.J. Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release. J. Neurochem. 2006, 98:258-266.
233. Thurston G. Role of angiopoietins and tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell Tissue Res. 2003, 314:61-68.
234. Timofeev I., Carpenter K.L., Nortje J., Al-Rawi P.G., O'Connell M.T., Czosnyka M., Smielewski P., Pickard J.D., Menon D.K., Kirkpatrick P.J., Gupta A.K., Hutchinson P.J. Cerebral extracellular chemistry and outcome following traumatic brain injury: a microdialysis study of 223 patients. Brain 2011, 134:484-494.
235. Toulmond S., Rothwell N.J. Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res. 1995, 671:261-266.
236. Ungerstedt U. Microdialysis-principles and applications for studies in animals and man. J. Intern. Med. 1991, 230:365-373.
237. Ungerstedt U., Rostami E. Microdialysis in neurointensive care. Curr. Pharm. Des. 2004, 10:2145-2152.
238. Unterberg A.W., Stover J., Kress B., Kiening K.L. Edema and brain trauma. Neuroscience 2004, 129:1021-1029.
239. Uzan M., Tanriverdi T., Baykara O., Kafadar A., Sanus G.Z., Tureci E., Ozkara C., Uysal O., Buyra N. Association between interleukin-1 beta (IL-1beta) gene polymorphism and outcome after head injury: an early report. Acta Neurochir. (Wien) 2005, 147:715-720. discussion 720.
240. Vadeboncoeur N., Segura M., Al-Numani D., Vanier G., Gottschalk M. Pro-inflammatory cytokine and chemokine release by human brain microvascular endothelial cells stimulated by Streptococcus suis serotype 2. FEMS Immunol. Med. Microbiol. 2003, 35:49-58.
241. Valable S., Montaner J., Bellail A., Berezowski V., Brillault J., Cecchelli R., Divoux D., Mackenzie E.T., Bernaudin M., Roussel S., Petit E. VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1. J. Cereb. Blood Flow Metab. 2005, 25:1491-1504.
242. van Bruggen N., Thibodeaux H., Palmer J.T., Lee W.P., Fu L., Cairns B., Tumas D., Gerlai R., Williams S.-P., Campagne M.v.L., Ferrara N. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J. Clin. Invest. 1999, 104:1613-1620.
243. Vecil G.G., Larsen P.H., Corley S.M., Herx L.M., Besson A., Goodyer C.G., Yong V.W. Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. J. Neurosci. Res. 2000, 61:212-224.
244. Veltkamp R., Siebing D.A., Sun L., Heiland S., Bieber K., Marti H.H., Nagel S., Schwab S., Schwaninger M. Hyperbaric oxygen reduces blood-brain barrier damage and edema after transient focal cerebral ischemia. Stroke 2005, 36:1679-1683.
245. Vige X., Costa E., Wise B.C. Mechanism of nerve growth factor mRNA regulation by interleukin-1 and basic fibroblast growth factor in primary cultures of rat astrocytes. Mol. Pharmacol. 1991, 40:186-192.
246. Viviani B., Bartesaghi S., Corsini E., Galli C.L., Marinovich M. Cytokines role in neurodegenerative events. Toxicol. Lett. 2004, 149:85-89.
247. Waelgaard L., Pharo A., Tonnessen T.I., Mollnes T.E. Microdialysis for monitoring inflammation: efficient recovery of cytokines and anaphylotoxins provided optimal catheter pore size and fluid velocity conditions. Scand. J. Immunol. 2006, 64:345-352.
248. Wajant H., Pfizenmaier K., Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003, 10:45-65.
249. Walker M.C., Tong X., Perry H., Alavijeh M.S., Patsalos P.N. Comparison of serum, cerebrospinal fluid and brain extracellular fluid pharmacokinetics of lamotrigine. Br. J. Pharmacol. 2000, 130:242-248.
250. Wang X., Stenken J.A. Microdialysis sampling membrane performance during in vitro macromolecule collection. Anal. Chem. 2006, 78:6026-6034.
251. Wang Y., Kilic E., Kilic U., Weber B., Bassetti C.L., Marti H.H., Hermann D.M. VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain 2005, 128:52-63.
252. Wang Y., Stenken J.A. Affinity-based microdialysis sampling using heparin for in vitro collection of human cytokines. Anal. Chim. Acta 2009, 651:105-111.
253. Wei L.H., Kuo M.L., Chen C.A., Chou C.H., Lai K.B., Lee C.N., Hsieh C.Y. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 2003, 22:1517-1527.
254. Whalen M.J., Carlos T.M., Kochanek P.M., Wisniewski S.R., Bell M.J., Clark R.S., DeKosky S.T., Marion D.W., Adelson P.D. Interleukin-8 is increased in cerebrospinal fluid of children with severe head injury. Crit. Care Med. 2000, 28:929-934.
255. Winter C.D., Iannotti F., Pringle A.K., Trikkas C., Clough G.F., Church M.K. A microdialysis method for the recovery of IL-1beta, IL-6 and nerve growth factor from human brain in vivo. J. Neurosci. Methods 2002, 119:45-50.
256. Winter C.D., Pringle A.K., Clough G.F., Church M.K. Raised parenchymal interleukin-6 levels correlate with improved outcome after traumatic brain injury. Brain 2004, 127:315-320.
257. Woodruff T.M., Ager R.R., Tenner A.J., Noakes P.G., Taylor S.M. The role of the complement system and the activation fragment C5a in the central nervous system. Neuromol. Med. 2010, 12:179-192.
258. Yager P.H., You Z., Qin T., Kim H.H., Takahashi K., Ezekowitz A.B., Stahl G.L., Carroll M.C., Whalen M.J. Mannose binding lectin gene deficiency increases susceptibility to traumatic brain injury in mice. J. Cereb. Blood Flow Metab. 2008, 28:1030-1039.
259. Yanamadala V., Friedlander R.M. Complement in neuroprotection and neurodegeneration. Trends Mol. Med. 2010, 16:69-76.
260. Yang J., You Z., Kim H.H., Hwang S.K., Khuman J., Guo S., Lo E.H., Whalen M.J. Genetic analysis of the role of tumor necrosis factor receptors in functional outcome after traumatic brain injury in mice. J. Neurotrauma 2010, 27:1037-1046.
261. Yao J.S., Zhai W., Young W.L., Yang G.Y. Interleukin-6 triggers human cerebral endothelial cells proliferation and migration: the role for KDR and MMP-9. Biochem. Biophys. Res. Commun. 2006, 342:1396-1404.
262. Yatsiv I., Morganti-Kossmann M.C., Perez D., Dinarello C.A., Novick D., Rubinstein M., Otto V.I., Rancan M., Kossmann T., Redaelli C.A., Trentz O., Shohami E., Stahel P.F. Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury. J. Cereb. Blood Flow Metab. 2002, 22:971-978.
263. Yeh W.-L., Lu D.-Y., Lin C.-J., Liou H.-C., Fu W.-M. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1{alpha} accumulation and VEGF expression. Mol. Pharmacol. 2007, 72:440-449.
264. You Z., Yang J., Takahashi K., Yager P.H., Kim H.H., Qin T., Stahl G.L., Ezekowitz R.A., Carroll M.C., Whalen M.J. Reduced tissue damage and improved recovery of motor function after traumatic brain injury in mice deficient in complement component C4. J. Cereb. Blood Flow Metab. 2007, 27:1954-1964.
265. Zhang Z.G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., Bruggen N., Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 2000, 106:829-838.
266. Zhang Z.G., Zhang L., Tsang W., Soltanian-Zadeh H., Morris D., Zhang R., Goussev A., Powers C., Yeich T., Chopp M. Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 2002, 22:379-392.
267. Zhao L., Zhang M.M., Ng K.Y. Effects of vascular permeability factor on the permeability of cultured endothelial cells from brain capillaries. J. Cardiovasc. Pharmacol. 1998, 32:1-4.
268. Zhao L.N., Yang Z.H., Liu Y.H., Ying H.Q., Zhang H., Xue Y.X. Vascular endothelial growth factor increases permeability of the blood-tumor barrier via caveolae-mediated transcellular pathway. J. Mol. Neurosci. 2010.
269. Ziebell J.M., Morganti-Kossmann M.C. Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 2010, 7:22-30.